key: cord-0078975-o9nsc6un authors: Venceslau, Marianna Tavares; Lebreiro, Giuliana Pucarelli; Leitão, Gabrielly de Souza; Alves, Brenda Klemm Arci Mattos de Freitas; Gouvea, Luane Abdalla; Pastura, Giuseppe Mario Carmine; Anachoreta, Thiago Dias; da Rocha, Regina Cláudia Silva; Maciel, Fernanda Queiroz; Cordeiro, Catherine Crespo; Castiñeiras, Terezinha Marta Pereira Pinto; Abreu, Thalita Fernandes; Frota, Ana Cristina Cisne; Varella, Rafael Brandão; Guimarães, Maria Angelica Arpon Marandino; Hofer, Cristina Barroso title: Neurological Manifestations Associated With SARS-CoV-2 in Children: A Case Series date: 2022-05-22 journal: J Cent Nerv Syst Dis DOI: 10.1177/11795735221102740 sha: ba4b5d071b41c2bd6081d7e79a31cae7ad842d0f doc_id: 78975 cord_uid: o9nsc6un Neurological manifestations of COVID-19 may affect both central and peripheral nervous systems. Unlike in adults, in whom majority of severe cases derive from respiratory complications, neurological involvement is one of the main causes of severe COVID-19 in children. This study aimed to detect viral respiratory pathogens, mainly SARS-CoV-2, in nasopharynx and cerebrospinal fluid samples utilizing qRT-PCR (TaqMan) in a pediatric population in Brazil. We evaluated four children with neurological symptoms and laboratory-confirmed SARS-CoV-2 infection: three presenting with meningoencephalitis and one presenting with Guillain-Barré syndrome. All four patients had mild respiratory symptoms. SARS-CoV-2 RNA was identified in two cerebrospinal fluid samples. SARS-CoV-2 involvement should be considered for differential diagnosis in pediatric cases presenting neurological alterations even if symptoms such as headache, anosmia, or dizziness are absent. Since December of 2019, over 468 million confirmed cases of coronavirus disease 2019 (COVID-19) have been confirmed worldwide, accounting for over 6 million deaths. 1 With over 29 million cases overall and more than 40 thousand hospitalizations in patients under 19 years of age, Brazil is the third leading country in case numbers at the time of writing. 2 Apart from the main respiratory manifestations, there is cumulative evidence that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has neuroinvasive potential and can be associated with several neurological conditions such as encephalitis, meningitis, Guillain-Barre, and Miller-Fisher syndrome. 3, 4 Studies have shown neurological symptoms in children are prevalent, often being the main manifestation of the infection. 5 Neurological symptoms may appear concomitantly or after the onset of respiratory manifestations. Although, it is not yet determined if such neurological involvement derives directly from the infection, is para-infectious or post-infectious process, SARS-CoV-2 RNA has been detected in cerebrospinal fluid (CSF) of adults and children. 6 However, reports on isolation of SARS-CoV-2 in cerebrospinal fluid (CSF) are inconsistent, exhibiting knowledge gaps of its effects on the central nervous system. 7, 8 Additionally, reports regarding neurological complications associated with COVID-19 in the pediatric population are still scarce. Children predominantly present with milder cases and better prognosis than adults. This observed four pediatric patients with neurological symptoms caused by mild COVID-19 infection treated at Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), a tertiary-care hospital in Rio de Janeiro, Brazil. Nasopharyngeal swabs and CSF samples were collected in sterile tubes or containers and submitted to qRT-PCR for SARS-CoV-2 (CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel and Bio-Manguinhos SARS-CoV-2 Molecular Kit) as well as XGen Multi PR21 Respiratory Panel (Mobius Life Science) and FilmArray ® Meningitis-Encephalitis (ME) Panel (Bio-MérieuxÔ). Positive (Ct≤36) and indeterminate (Ct 36